Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Impaired Liver Function”

414 trials

Showing 20 of 414 results

Not applicableUnknownNCT02893657
What this trial is testing

The Role and Dynamics of Liver Dysfunction in Patients Undergoing Cardiac Surgery

Who this might be right for
Cardiac SurgeryHepatic ImpairmentHeart Failure
Semmelweis University Heart and Vascular Center 150
Early research (Phase 1)Not Yet RecruitingNCT07248839
What this trial is testing

Assess the Drug Levels and Safety of BMS-986435 in Participants With Normal Hepatic Function and Participants With Different Degrees of Hepatic Impairment

Who this might be right for
Healthy VolunteersHepatic Impairment
Bristol-Myers Squibb 24
Early research (Phase 1)Study completedNCT03521037
What this trial is testing

Rucaparib Hepatic Impairment Study in Patients With a Solid Tumor

Who this might be right for
Neoplasms
pharmaand GmbH 16
Early research (Phase 1)Study completedNCT01670734
What this trial is testing

Pharmacokinetic and Tolerability of Alirocumab SAR236553 (REGN727) in Patients With Hepatic Impairment and in Healthy Subjects

Who this might be right for
Hypercholesterolemia
Sanofi 25
Early research (Phase 1)Study completedNCT01299454
What this trial is testing

A Study Evaluating the of OPC-34712 in Subjects With Normal Hepatic Function and Hepatically Impaired Subjects

Who this might be right for
Schizophrenia
Otsuka Pharmaceutical Development & Commercialization, Inc. 45
Early research (Phase 1)Study completedNCT01443481
What this trial is testing

Pharmacokinetics (PK) of TKI258 in Cancer Patients With Normal and Impaired Hepatic Function

Who this might be right for
Solid TumorsHepatic Impairment
Novartis Pharmaceuticals 38
Early research (Phase 1)Study completedNCT06485401
What this trial is testing

To Compare the Safety and PK/ PD Characteristics of ADC189 Between Hepatic Impairment and Normal Hepatic Function Subjects

Who this might be right for
Influenza Type AInfluenza Type B
Jiaxing AnDiCon Biotech Co.,Ltd 16
Not applicableUnknownNCT00553553
What this trial is testing

Efficacy of Multimodal Opioid Therapy During Hepatic Resection Surgery

Who this might be right for
Liver DysfunctionPain
St Vincent's University Hospital, Ireland 45
Post-approval studies (Phase 4)UnknownNCT02260102
What this trial is testing

Temocillin Pharmacokinetics in Paediatrics

Who this might be right for
InfectionLiver DysfunctionUrinary Tract Infection
Université Catholique de Louvain 45
Post-approval studies (Phase 4)UnknownNCT06220929
What this trial is testing

Mecobalamin Combined With Ceftriaxone Sodium in the Treatment of Sepsis Liver Injury

Who this might be right for
SepsisLiver Dysfunction
Sichuan Provincial People's Hospital 40
Early research (Phase 1)Study completedNCT02765724
What this trial is testing

Determine Pacritinib Pharmacokinetics in Impaired Hepatic Patients and Healthy Subjects

Who this might be right for
Myelofibrosis
CTI BioPharma 28
Early research (Phase 1)Study completedNCT05765344
What this trial is testing

Study of Bulevirtide in Participants Who Have Normal or Impaired Liver Function

Who this might be right for
Hepatic ImpairmentHealthy
Gilead Sciences 74
Early research (Phase 1)Study completedNCT00621881
What this trial is testing

Compare the PK and Safety of Naproxcinod in Hepatic Impaired Patients and Matching Healthy Subjects

Who this might be right for
Liver Disease
NicOx 24
Early research (Phase 1)Study completedNCT06736340
What this trial is testing

Pharmacokinetics and Safety of Rupatadine in Participants With Hepatic Impairment Compared to Control Participants.

Who this might be right for
Hepatic Impairment
Noucor Health S.A. 26
Early research (Phase 1)Study completedNCT02536911
What this trial is testing

The Effects of Hepatic Impairment on the Pharmacokinetics and Tolerability of Eliglustat Tartrate

Who this might be right for
Gaucher Disease
Genzyme, a Sanofi Company 24
Not applicableStudy completedNCT02733549
What this trial is testing

Is The Sudden Onset of Dizziness A Symptom of Acute Liver Dysfunction?

Who this might be right for
Dizziness
Adiyaman University Research Hospital 198
Not applicableStudy completedNCT01700231
What this trial is testing

Plasma and Hemodynamic Markers During Hepatectomy

Who this might be right for
Hepatorenal Syndrome, Liver Regeneration
Medical University of Vienna 100
Early research (Phase 1)Study completedNCT03627754
What this trial is testing

Evaluate the Effect of Hepatic Impairment on the Pharmacokinetics of Glasdegib

Who this might be right for
Hepatic Impairment
Pfizer 24
Early research (Phase 1)Ended earlyNCT05209295
What this trial is testing

Evaluate CC-486/Onureg in Participants With Moderate or Severe Hepatic Impairment Compared With Normal Hepatic Function in Participants With Myeloid Malignancies

Who this might be right for
Hepatic InsufficiencyNeoplasms
Bristol-Myers Squibb 2
Early research (Phase 1)Study completedNCT05440344
What this trial is testing

Imlunestrant (LY3484356) in Female Participants With Impaired Liver Function

Who this might be right for
Hepatic InsufficiencyHealthy
Eli Lilly and Company 27
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation